BioSpace News Archive

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the second quarter ended September 30, 2020 on Wednesday, October 28th, 2020 after the Board Meeting.

- Data demonstrates highly reliable test results with 99.56% specificity and 95.00% sensitivity for patients tested 15 days after symptom onset - Availability of the new IgM blood test on the ARCHITECT® and Alinity™ platforms is part of Abbott’s effort to offer tests across the disease progression of COVID-19 - Abbott’s IgM test will give a more complete picture of where patients are in their recovery [12-October-202

Exact Sciences Corp. (NASDAQ: EXAS) today announced the introduction of the Oncotype MAP™ Pan-Cancer Tissue test for patients with advanced, metastatic, refractory, or recurrent cancer. The Oncotype

New PERSIST-AVR study results and SURE-AVR registry data analysis underscore utility of Perceval as a minimally invasive surgical approach for patients with aortic valve stenosis LONDON--( BUSINESS WIRE )-- LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today announced new data from the Perceval ® Sutureless Implant Versus Standard-Aortic Valve Replacement (PERSIST-AVR) clinical study and the Sorin Universa

Bayer will present detailed results from the Phase III FIDELIO-DKD study assessing the use of the investigational drug finerenone on kidney and cardiovascular outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) during scientific sessions of the upcoming American Society of Nephrology’s (ASN) Kidney Week, October 22-25, 2020. Addition

Reducing payment and reimbursement barriers is the most important factor in driving provider uptake of cell and gene therapies, the Alliance for Regenerative Medicine (ARM) and the National Association of Managed Care Physicians (NAMCP) Medical Directors Institute concluded in a joint study announced today.

MerckManuals.com calls on patients and professionals to show their commitment to trusted, reliable medical knowledge in worldwide day of action

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today the appointment of Serena Robella as Director of Sales.

Fund seeks applications from local non-profits in affected communities in Silicon Valley, South Bay and Detroit metro area

GEHA today announced that Mary Beth Vitale, Corporate Director, has been named one of the most influential leaders in the boardroom by the National Association of Corporate Directors (NACD) as part of their 2020 NACD Directorship 100™, an annual list of leading corporate directors and governance advocates.